Opportunity Information: Apply for HRSA 21 057
The AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) is a discretionary grant opportunity administered by the U.S. Department of Health and Human Services through the Health Resources and Services Administration (HRSA), specifically the HIV/AIDS Bureau (HAB) and its Division of State HIV/AIDS Programs (DSHAP). It sits under the Ryan White HIV/AIDS Program (RWHAP) Part B framework and is meant to give states and territories an extra financial backstop when their ADAP programs face sudden or unusually high demand that could threaten timely access to HIV medications and related treatment support.
The central purpose of the ADAP ERF is to provide additional resources to prevent, reduce, or eliminate ADAP waiting lists. While the program historically responded to periods when many jurisdictions had formal waiting lists for medication assistance, this funding opportunity makes clear that HRSA is focused on preventing those lists from reappearing in the first place, as well as responding quickly if they do. If a state or territory establishes a waiting list after the notice is published, it must report that waiting list to HRSA immediately, and any ERF funding it receives is expected to be used to remove clients from the waiting list. Even though the notice notes that there were no ADAP waiting lists at the time of publication, HRSA anticipates that changing economic conditions can quickly increase need, especially when clients lose income or health coverage and newly turn to ADAP for help.
Funding decisions are driven by demonstrated need rather than a simple formula. Applicants must make a strong case that additional dollars are necessary to maintain access to medications and prevent service disruptions. HRSA bases awards on an applicant's ability to successfully demonstrate the need for more funding, and an external objective review committee evaluates applications using criteria spelled out in the notice of funding opportunity. The review process places priority on jurisdictions that are addressing existing waiting lists, but it also supports requests aimed at preventing projected waiting lists or responding to other unanticipated increases in the number of clients needing ADAP services.
The notice also highlights that ERF dollars can support cost-containment approaches that help keep clients in care without forcing programs to cap enrollment. One example specifically mentioned is the provision of health insurance assistance, which can be used as a strategy to manage program costs while ensuring clients can still access necessary medications through insurance coverage rather than solely through direct medication purchasing. More broadly, states and territories may use ERF funds to respond to current or projected increases in treatment needs that align with broader public health goals such as ending the HIV epidemic, as well as to handle unexpected surges in caseload that strain the ADAP system.
Eligibility is geared toward state and territorial ADAP programs under RWHAP Part B, and the notice emphasizes a shift from earlier years when eligibility was more narrowly limited to jurisdictions with a history of waiting lists. The expectation in this cycle is that economic downturn conditions may affect many jurisdictions, not only those that previously experienced waiting lists. Applicants are encouraged to frame proposed activities in a way that reflects HRSA priorities around innovation, collaboration, impact, and effectiveness, meaning proposals should show practical strategies, coordination with partners, and clear results in maintaining or expanding access to HIV treatment.
Key administrative details in the notice include the funding opportunity number HRSA-21-057 and the CFDA listing 93.917. The opportunity was posted on July 27, 2020, with an original application closing date of October 26, 2020. HRSA anticipated making around 30 awards. The published award ceiling is listed as 0, which typically signals that awards may vary based on available funds and demonstrated need rather than having a fixed maximum stated in the synopsis.Apply for HRSA 21 057
- The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917.
- This funding opportunity was created on Jul 27, 2020.
- Applicants must submit their applications by Oct 26, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 30 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
ADAP Emergency Relief Fund (ERF) - Frequently Asked Questions
What is the ADAP Emergency Relief Fund (ERF)?
The AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) is a discretionary grant opportunity that provides extra financial support to help state and territorial ADAP programs respond to sudden or unusually high demand that could threaten timely access to HIV medications and related treatment support.
Which federal agency administers this grant opportunity?
This opportunity is administered by the U.S. Department of Health and Human Services (HHS) through the Health Resources and Services Administration (HRSA), specifically HRSA's HIV/AIDS Bureau (HAB) and its Division of State HIV/AIDS Programs (DSHAP).
How does the ERF relate to the Ryan White HIV/AIDS Program (RWHAP)?
The ERF sits under the Ryan White HIV/AIDS Program (RWHAP) Part B framework and is designed to serve as an added financial backstop for Part B ADAP programs facing unexpected increases in demand.
What is the main purpose of ERF funding?
The central purpose of ERF funding is to provide additional resources to prevent, reduce, or eliminate ADAP waiting lists, and to avoid service disruptions that could affect access to HIV medications.
Is HRSA focusing more on eliminating waiting lists or preventing them?
The notice makes clear that HRSA is focused on both, with strong emphasis on preventing waiting lists from reappearing while also responding quickly if a waiting list is established.
What must a state or territory do if it establishes an ADAP waiting list after the notice is published?
If a state or territory establishes a waiting list after the notice is published, it must report the waiting list to HRSA immediately. Any ERF funding received is expected to be used to remove clients from the waiting list.
Were there ADAP waiting lists at the time this notice was published?
The notice states there were no ADAP waiting lists at the time of publication, but HRSA anticipated that changing economic conditions could quickly increase need.
Why does HRSA anticipate future increases in ADAP demand?
HRSA notes that economic conditions can shift quickly, especially when clients lose income or health coverage and newly turn to ADAP for help.
How are funding decisions made for ERF awards?
Funding decisions are driven by demonstrated need rather than a simple formula. Applicants are expected to make a strong case that additional funding is necessary to maintain medication access and prevent service disruptions.
Who evaluates ERF applications?
An external objective review committee evaluates applications using criteria described in the notice of funding opportunity.
Are jurisdictions with existing waiting lists prioritized?
Yes. The review process places priority on jurisdictions that are addressing existing waiting lists, while also supporting requests aimed at preventing projected waiting lists or responding to other unanticipated increases in clients needing ADAP services.
Can ERF funding be used even if a waiting list does not currently exist?
Yes. The opportunity supports funding requests intended to prevent projected waiting lists and to respond to unanticipated increases in the number of clients needing ADAP services.
What kinds of activities can ERF dollars support?
ERF dollars can support actions that maintain access to HIV medications and related treatment support, including cost-containment approaches intended to keep clients in care without forcing programs to cap enrollment.
Does the notice give an example of a cost-containment approach?
Yes. The notice specifically mentions health insurance assistance as an example strategy to help manage program costs while ensuring clients can still access necessary medications through insurance coverage rather than only through direct medication purchasing.
Can ERF funds be used to respond to increases in treatment needs beyond waiting lists?
Yes. The notice indicates that states and territories may use ERF funds to respond to current or projected increases in treatment needs, including unexpected surges in caseload that strain the ADAP system.
How does this opportunity connect to broader public health goals?
The notice describes ERF funding as supporting responses that align with broader public health goals such as ending the HIV epidemic, particularly when increased treatment demand threatens access.
Who is eligible to apply for this funding?
Eligibility is geared toward state and territorial ADAP programs under RWHAP Part B.
Has eligibility changed compared to earlier years?
The notice emphasizes a shift from earlier years when eligibility was more narrowly limited to jurisdictions with a history of waiting lists. In this cycle, HRSA anticipates that economic downturn conditions could affect many jurisdictions, not only those that previously had waiting lists.
What should applicants emphasize in their proposed activities?
Applicants are encouraged to frame proposed activities around HRSA priorities of innovation, collaboration, impact, and effectiveness. Proposals should describe practical strategies, coordination with partners, and clear results in maintaining or expanding access to HIV treatment.
What is the funding opportunity number for this grant?
The funding opportunity number is HRSA-21-057.
What is the CFDA listing for this opportunity?
The CFDA listing is 93.917.
When was this opportunity posted and when did it close?
The opportunity was posted on July 27, 2020, and the original application closing date was October 26, 2020.
How many awards did HRSA anticipate making?
HRSA anticipated making around 30 awards.
Is there a maximum award amount (award ceiling)?
The published award ceiling is listed as 0, which typically indicates that award amounts may vary based on available funds and demonstrated need rather than a fixed maximum amount being stated in the synopsis.
Browse more opportunities from the same category: Health
Next opportunity: Fostering Innovation and Entrepreneurship in Ukraine by Training Ukrainian Start-up Owners on Sustainable Financing
Previous opportunity: State Local Tribal and Territorial (SLTT) Reporting and Threat Information Sharing Pilot
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 21 057
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 21 057) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health Apply for CDC RFA OT18 18020302SUPP20 Funding Number: CDC RFA OT18 18020302SUPP20 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives Apply for MP CPI 20 002 Funding Number: MP CPI 20 002 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,250,000 |
| Community Health Services (CHS) Apply for 72066920RFA00001 Funding Number: 72066920RFA00001 Agency: Agency for International Development, Liberia USAID-Monrovia Category: Health Funding Amount: $17,800,000 |
| 2020 Supplemental Budget Request Apply for CMS 1LI 20 001 Funding Number: CMS 1LI 20 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $70,000,000 |
| Office of Tribal Self-Governance Negotiation Cooperative Agreement Apply for HHS 2020 IHS TSGN 0001 Funding Number: HHS 2020 IHS TSGN 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $48,000 |
| Office of Tribal Self-Governance Planning Cooperative Agreement Apply for HHS 2020 IHS TSGP 0001 Funding Number: HHS 2020 IHS TSGP 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $120,000 |
| Extension of the World Trade Center Health Registry Apply for RFA OH 21 003 Funding Number: RFA OH 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $7,000,000 |
| Kenya Health Partnerships for Quality Services (KHPQS) – HIV and OVC Apply for 72061520RFA00007 Funding Number: 72061520RFA00007 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $23,311,454 |
| KENYA HEALTH PARTNERSHIPS FOR QUALITY SERVICES - HIV, FP/RMNCAH, Nutrition and WASH Apply for 72061520RFA00004 Funding Number: 72061520RFA00004 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $144,199,034 |
| HIV,FP/RMNACH,Nutrition, WASH,DREAMS and OVC Apply for 72061520RFA00005 Funding Number: 72061520RFA00005 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $74,000,000 |
| Kenya Health Partnerships for Quality Services (KHPQS) – OVC and DREAMS Apply for 72061520RFA00006 Funding Number: 72061520RFA00006 Agency: Agency for International Development, Kenya USAID-Nairobi Category: Health Funding Amount: $55,418,628 |
| Cooperative Research Agreements Related to the World Trade Center Health Program (U01) Apply for RFA OH 21 002 Funding Number: RFA OH 21 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $600,000 |
| County Government Implementation, Management and Sustainability of High Quality HIV Services in Homa Bay, Kiambu, Kirinyaga, Kisii, Kisumu, Kitui, Machakos, Makueni, Migori, Muranga, Nairobi, and Nyeri Counties in the Republic of Kenya under PEPFAR Apply for CDC RFA GH20 2084 Funding Number: CDC RFA GH20 2084 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Accelerating and Expanding LOINC® Development to Support Public Health Needs Apply for COVID C3 20 004 Funding Number: COVID C3 20 004 Agency: Department of Health and Human Services, Office of the National Coordinator Category: Health Funding Amount: $1,500,000 |
| Strengthening the Technical Advancement & Readiness of Public Health via Health Information Exchange Program Apply for COVID C3 20 002 Funding Number: COVID C3 20 002 Agency: Department of Health and Human Services, Office of the National Coordinator Category: Health Funding Amount: $500,000 |
| Public Health Emergency Response Related HL7® Standards, Solutions and Future Pandemics Apply for COVID C3 20 003 Funding Number: COVID C3 20 003 Agency: Department of Health and Human Services, Office of the National Coordinator Category: Health Funding Amount: $2,000,000 |
| Tracking Use and Impacts of Health IT on U.S. Office-Based Physicians Apply for NAP AX 20 001 Funding Number: NAP AX 20 001 Agency: Department of Health and Human Services, Office of the National Coordinator Category: Health Funding Amount: $290,000 |
| Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers Apply for RFA PS 21 001 Funding Number: RFA PS 21 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| PEPFAR Community Led Monitoring - Zambia Apply for PCLM 2020 Funding Number: PCLM 2020 Agency: Department of State, U.S. Mission to Zambia Category: Health Funding Amount: $125,000 |
| Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) Apply for RFA OH 21 004 Funding Number: RFA OH 21 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 21 057", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.